Philip Morris International (PM) Stock Could Be 5.9% Undervalued After Dividend And 2026 Guidance

Philip Morris International (PM) is back in focus after reaffirming a quarterly dividend of $1.47 per share and updating its 2026 earnings guidance, as smoke-free products take a larger share of revenue.

See our latest analysis for Philip Morris International.

Philip Morris International’s recent dividend reaffirmation and updated 2026 earnings guidance come after a period where the share price is up 13.42% year to date, while the 5 year total shareholder return of 130.17% highlights how dividend reinvestment and price gains have combined over time.

If you are using Philip Morris International as a starting point for your research, it can also be useful to see what else is working in related themes, including 20 top founder-led companies

So with Philip Morris International stock trading near its recent gains and fair value estimates sitting only slightly above the last close, is the market leaving a margin of safety here or already pricing in much of the smoke free growth story?

Most Popular Narrative: 5.9% Undervalued

Philip Morris International’s most followed narrative points to a fair value of $193.14, a touch above the last close of $181.81. This frames the current debate around how much of the smoke free transition is already embedded in the price.

The accelerating global adoption of smoke-free alternatives, driven by increasing health awareness and regulatory moves away from combustibles, is fueling strong double-digit volume and margin growth in PMI's IQOS, ZYN, and VEEV platforms. This secular shift enables the company to capture new consumer segments, expand its addressable market, and structurally boost net revenues and operating margins over time.

Read the complete narrative.

Curious what sits underneath that smoke free pivot and mid single digit revenue growth assumption? The narrative leans on richer margins, a higher future earnings base, and a premium multiple that still compresses slightly from today. The full storyline connects those moving parts into one fair value range.

Result: Fair Value of $193.14 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, that smoke free narrative for Philip Morris International still leans on continued regulatory support and steady IQOS and ZYN momentum, both of which could disappoint.

Find out about the key risks to this Philip Morris International narrative.

Another View on Philip Morris International Using Market Multiples

While the popular Philip Morris International narrative points to a fair value of $193.14, the market is currently assigning a P/E of 25.6x. That sits above the peer average of 19.9x and above a fair ratio of 25.3x, which tilts this lens toward a richer pricing picture.

This gap suggests less room for error if earnings or sentiment wobble. The key question for investors is whether Philip Morris International has enough earnings resilience to justify sitting above both peers and the fair ratio over time.

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

With both optimism around smoke free products and concern about risks in the mix, it makes sense to review the data yourself and move quickly to shape your own view by checking the 3 key rewards and 1 important warning sign

Looking for more investment ideas beyond Philip Morris International?

If you stop with Philip Morris International, you risk missing other opportunities that could suit your goals. Widen your research using focused stock lists.

• Zero in on potential value opportunities by reviewing companies filtered as 47 high quality undervalued stocks.
• Strengthen your income focus by scanning stocks highlighted as 9 dividend fortresses.
• Prioritize resilience and peace of mind by assessing candidates within the 68 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com